The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The p53 tumour-suppressor protein controls the expression of a gene encoding the p21 cyclin-dependent protein kinase (CDK) regulator. Levels of p21 protein are increased in senescent cells and p21 overexpression blocks the growth of tumour cells. In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen (PCNA). p21 controls CDK activity, thereby affecting cell-cycle control, whereas PCNA functions in both DNA replication and repair. Here we use simian virus 40 DNA replication in vitro to show than p21 directly inhibits PCNA-dependent DNA replication in the absence of a cyclin/CDK. Furthermore, p21 blocks the ability of PCNA to activate DNA polymerase delta, the principal replicative DNA polymerase. This regulation results from a direct interaction between p21 and PCNA. Thus, during p53-mediated suppression of cell proliferation, p21 and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 was reported to block replicative DNA synthesis in vitro as well, doing so when reaching a 100:1 ratio [42,43,44].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [44]
In the citing paper
“suggesting that p21–PCNA interaction prevented rather than promoted cell-cycle arrest, as originally postulated based on its ability to displace replicative DNA polymerases from PCNA [43,44].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [44]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Self-citationp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Self-citationKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Self-citationProliferating cell nuclear antigen is required for DNA excision repair
Shivji, M. K. K., Kenny, M. K., & Wood, R. D. (1992) · Cell · doi:10.1016/0092-8674(92)90416-a · Cited by 798
Cited by
Items 201–300 of 1,000
Barnouin, K., Dubuisson, M. L., Child, E. S., Fernandez de Mattos, S., Glassford, J., Medema, R. H., Mann, D. J., & Lam, E. W.-F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111123200 · Cited by 161
Mechanism Whereby Proliferating Cell Nuclear Antigen Stimulates Flap Endonuclease 1
Tom, S., Henricksen, L. A., & Bambara, R. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10498 · Cited by 162
Two modes of FEN1 binding to PCNA regulated by DNA
Gomes, X. V., & Burgers, P. M. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.14.3811 · Cited by 162
Ito, Y., Matsuura, N., Sakon, M., Miyoshi, E., Noda, K., Takeda, T., Umeshita, K., Nagano, H., Nakamori, S., Dono, K., et al. (1999) · Hepatology · doi:10.1002/hep.510300114 · Cited by 162
Ishida, A., Sasaguri, T., Kosaka, C., Nojima, H., & Ogata, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10050 · Cited by 161
Lee, S. J., Ha, M. J., Lee, J., Nguyen, P., Choi, Y. H., Pirnia, F., Kang, W.-K., Wang, X.-F., Kim, S.-J., & Trepel, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10618 · Cited by 160
The UHRF family: Oncogenes that are drugable targets for cancer therapy in the near future?
Bronner, C., Achour, M., Arima, Y., Chataigneau, T., Saya, H., & Schini-Kerth, V. B. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.003 · Cited by 159
Yang, G., Cao, K., Wu, L., & Wang, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408997200 · Cited by 159
Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues
Pei, X.-H., & Xiong, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208611 · Cited by 158
Blalock, W., Weinstein-Oppenheimer, C., Chang, F., Hoyle, P., Wang, X.-Y., Algate, P., Franklin, R., Oberhaus, S., Steelman, L., & McCubrey, J. (1999) · Leukemia · doi:10.1038/sj.leu.2401493 · Cited by 158
Cytoplasmic p21Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity
Tanaka, H., Yamashita, T., Asada, M., Mizutani, S., Yoshikawa, H., & Tohyama, M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202071 · Cited by 157
Yan, G.-Z., & Ziff, E. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06122.1997 · Cited by 157
UV-induced binding of ING1 to PCNA regulates the induction of apoptosis
Scott, M. S., Bonnefin, P., Vieyra, D. S., Boisvert, F., Young, D., Bazett‐Jones, D. P., & Riabowol, K. T. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.19.3455 · Cited by 161
Watanabe, H. A., Pan, Z., Schreiber‐Agus, N., DePinho, R. A., Hurwitz, J., & Xiong, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1392 · Cited by 175
Inhibitors of the Cip/Kip Family
Hengst, L., & Reed, S. I. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_2 · Cited by 188
Dantzer, F., Nasheuer, H. P., Vonesch, J. L., de Murcia, G., & Murcia, J. M.-D. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.8.1891 · Cited by 178
Hypoxic stress proteins: Survival of the fittest
Giaccia, A. J. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80035-x · Cited by 154
Gorospe, M., Wang, X., Guyton, K. Z., & Holbrook, N. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6654 · Cited by 154
Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure
Megyesi, J., Andrade, L., Vieira, J. M., Safirstein, R. L., & Price, P. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00044.x · Cited by 153
Apoptosis, cancer and the p53 tumour suppressor gene
Lee, J. M., & Bernstein, A. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00665797 · Cited by 169
Protein–PCNA interactions: a DNA-scanning mechanism?
Kelman, Z., & Hurwitz, J. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01223-7 · Cited by 169
Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21
Pan, Z.-Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., & Hurwitz, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22008 · Cited by 151
p53 and metabolism: from mechanism to therapeutics
Simabuco, F. M., Morale, M. G., Pavan, I. C. B., Morelli, A. P., Silva, F. R., & Tamura, R. E. (2018) · Oncotarget · doi:10.18632/oncotarget.25267 · Cited by 171
Zezula, J., Casaccia‐Bonnefil, P., Ezhevsky, S. A., Osterhout, D. J., Levine, J. M., Dowdy, S. F., Chao, M. V., & Koff, A. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve008 · Cited by 160
Zuccola, H. J., Filman, D. J., Coen, D. M., & Hogle, J. M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80422-0 · Cited by 151
p 21WAF1 C ontrol of E pithelial C ell C ycle and C ell F ate
Weinberg, W. C., & Denning, M. F. (2002) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130201300603 · Cited by 150
The dual role model for p53 in maintaining genomic integrity
Janus, F., Albrechtsen, N. J. W., Dornreiter, I., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050266 · Cited by 351
Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin
Ramachandran, C., & You, W. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006170224414 · Cited by 159
The Initiation of Simian Virus 40 DNA ReplicationIn Vitro
Bullock, P. A., & Simmons, D. T. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082001 · Cited by 166
Coqueret, O., Bérubé, G., & Nepveu, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4680 · Cited by 171
Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision—repair
Shivji, M. K. K., Grey, S. J., Strausfeld, U. P., Wood, R. D., & Blow, J. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00244-x · Cited by 170
Regulation of p21WAF1/CIP1 Stability by WISp39, a Hsp90 Binding TPR Protein
Jascur, T., Brickner, H., Salles-Passador, I., Barbier, V., El Khissiin, A., Smith, B., Fotedar, R., & Fotedar, A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.049 · Cited by 145
Akutsu, N., Lin, R., Bastien, Y., Bestawros, A., Enepekides, D. J., Black, M. J., & White, J. H. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.7.0655 · Cited by 145
The Role of p53 in Cell Cycle Regulation
Shaw, P. H. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80088-4 · Cited by 169
Lapillonne, H., Konopleva, M. Y., Tsao, T., Gold, D. L., McQueen, T. J., Sutherland, R. L., Madden, T. L., & Andreeff, M. (2003) · PubMed · Cited by 160
Cenciarelli, C., De Santa, F., Puri, P. L., Mattei, E., Ricci, L., Bucci, F., Felsani, A., & Caruso, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5203 · Cited by 143
Cyclin-Dependent Kinase Regulation during G1 Phase and Cell Cycle Regulation by TGF-ß
Ravitz, M. J., & Wenner, C. E. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60099-8 · Cited by 168
Control of E2F activity by p21Waf1/Cip1
Delavaine, L., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202923 · Cited by 188
Arima, Y., Hirota, T., Bronner, C., Mousli, M., Fujiwara, T., Niwa, S., Ishikawa, H., & Saya, H. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00710.x · Cited by 142
Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage
Li, R., Hannon, G. J., Beach, D., & Stillman, B. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00452-9 · Cited by 161
Self-citationAdnane, J., Bizouarn, F. A., Qian, Y., Hamilton, A. D., & Sebti, S. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.6962 · Cited by 141
FAR1 is required for oriented polarization of yeast cells in response to mating pheromones.
Valtz, N., Peter, M., & Herskowitz, I. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.4.863 · Cited by 151
Zupkovitz, G., Grausenburger, R., Brunmeir, R., Senese, S., Tischler, J., Jurkin, J., Rembold, M., Meunier, D., Egger, G., Lagger, S., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01500-09 · Cited by 138
Defect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation
Beamish, H., Williams, R., Chen, P., & Lavin, M. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20486 · Cited by 137
Pisani, P., Parkin, D. M., Bray, F., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991210)83:6<870::aid-ijc35>3.0.co;2-9 · Cited by 860
Amsterdam, A., & Selvaraj, N. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.4.0306 · Cited by 148
A novel cytostatic process enhances the productivity of Chinese hamster ovary cells
Fussenegger, M., Mazur, X., & Bailey, J. E. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19970920)55:6<927::aid-bit10>3.0.co;2-4 · Cited by 136
Dimri, G. P., Nakanishi, M., Desprez, P.-Y., Smith, J. R., & Campisi, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2987 · Cited by 136
Tomita, K., Caramori, G., Lim, S., Ito, K., Hanazawa, T., Oates, T., Chiselita, I., Jazrawi, E., Chung, K. F., Barnes, P. J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2104010 · Cited by 137
Molecular biology of gastric cancer
Tahara, E. (1995) · World Journal of Surgery · doi:10.1007/bf00294705 · Cited by 133
C ell C ycle D ysregulation in O ral C ancer
Todd, R., Hinds, P. W., Münger, K., Rustgi, A. K., OPITZ, O. G., Suliman, Y., & Wong, D. T. (2002) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130201300106 · Cited by 162
Analysis of cell cycle arrest in adipocyte differentiation
Reichert, M., & Eick, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202308 · Cited by 155
Koundrioukoff, S., Jónsson, Z. O., Hasan, S., de Jong, R. N., van der Vliet, P. C., Hottiger, M. O., & Hübscher, U. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001850200 · Cited by 147
Shariat, S. F., Kim, J., Raptidis, G., Ayala, G. E., & Lerner, S. P. (2003) · Urology · doi:10.1016/s0090-4295(03)00236-x · Cited by 131
Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris, G. F., Bischoff, J. R., & Mathews, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.895 · Cited by 131
Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers
Ohashi, K., Tsutsumi, M., Nakajima, Y., Kobitsu, K., Nakano, H., & Konishi, Y. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8<1593::aid-cncr26>3.0.co;2-u · Cited by 43
The highly conserved nuclear lamin Ig-fold binds to PCNA: its role in DNA replication
Shumaker, D. K., Solimando, L., Sengupta, K., Shimi, T., Adam, S. A., Grunwald, A., Strelkov, S. V., Aebi, U., Cardoso, M. C., & Goldman, R. D. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708155 · Cited by 129
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Tsurimoto, T., Yoshikawa, H., Iguchi-Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10477 · Cited by 129
Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity
Dash, B. C., & El‐Deiry, W. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3364-3387.2005 · Cited by 160
p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells
Bromleigh, V. C., & Freedman, L. P. (2000) · Genes & Development · doi:10.1101/gad.817100 · Cited by 129
Vaishnavi, K., Saxena, N., Shah, N., Singh, R., Manjunath, K., Uthayakumar, M., Kanaujia, S. P., Kaul, S. C., Sekar, K., & Wadhwa, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044419 · Cited by 128
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T- cell leukemia/lymphoma
Roberta Morosetti, A., Kawamata, N., Gombart, A., Cw, M., Hatta, Y., Hirama, T., Jw, S., Tomonaga, M., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v86.5.1924.bloodjournal8651924 · Cited by 134
Strausfeld, U. P., Howell, M., Rempel, R. E., Maller, J. L., Hunt, T., & Blow, J. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00196-2 · Cited by 138
Mechanism of Hepatitis B Virus cccDNA Formation
Wei, L., & Ploß, A. (2021) · Viruses · doi:10.3390/v13081463 · Cited by 155
Joseph, B., Orlian, M., & Furneaux, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20511 · Cited by 127
PCNA, a multifunctional ring on DNA
Tsurimoto, T. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00204-8 · Cited by 139
The DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?
Fielder, E., von Zglinicki, T., & Jurk, D. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161221 · Cited by 126
Dore, A. S., Kilkenny, M. L., Rzechorzek, N. J., & Pearl, L. H. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.027 · Cited by 144
Primitive hematopoietic cells resist HIV-1 infection via p21Waf1/Cip1/Sdi1
Zhang, J., Scadden, D. T., & Crumpacker, C. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28971 · Cited by 124
Fan, Z., Lu, Y., Wu, X., DeBlasio, A., Koff, A., & Mendelsohn, J. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.1.235 · Cited by 125
Podust, V. N., Podust, L. M., Goubin, F., Ducommun, B., & Huebscher, U. (1995) · Biochemistry · doi:10.1021/bi00027a039 · Cited by 124
Regulating neutrophil apoptosis: new players enter the game
Witko‐Sarsat, V., Pederzoli-Ribeil, M., Hirsch, E., Sozzani, S., & Cassatella, M. A. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.001 · Cited by 143
Lipids as Regulators of Cellular Senescence
Hamsanathan, S., & Gurkar, A. U. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.796850 · Cited by 137
p53 and p21 Regulate Error-Prone DNA Repair to Yield a Lower Mutation Load
Avkin, S., Sevilya, Z., Toube, L., Geacintov, N. E., Chaney, S. G., Oren, M., & Livneh, Z. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.022 · Cited by 141
Muto, M., Kanari, Y., Kubo, E., Takabe, T., Kurihara, T., Fujimori, A., & Tatsumi, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205189200 · Cited by 125
Disruption of Nucleotide Excision Repair by the Human T-Cell Leukemia Virus Type 1 Tax Protein
Kao, S.-Y., & Marriott, S. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4299-4304.1999 · Cited by 123
DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair
O'Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l291 · Cited by 122
Noton, E., & Diffley, J. F. X. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80405-0 · Cited by 122
Cunningham, J. M., Kimmel, D. W., Scheithauer, B. W., O'Fallon, J. R., & Novotny, P. J. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.86.1.0121 · Cited by 118
p15PAF, a novel PCNA associated factor with increased expression in tumor tissues
Yu, P., Huang, B. C. B., Shen, M., Lau, C., Chan, E., Michel, J. J. C., Xiong, Y., Payan, D. G., & Luo, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204113 · Cited by 132
Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells
Condorelli, F., Gnemmi, I., Vallario, A., Genazzani, A. A., & Canonico, P. L. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707608 · Cited by 121
Chen, U., Chen, S., Saha, P., & Dutta, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11597 · Cited by 121
Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism?
Wright, W. E., & Shay, J. W. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89044-3 · Cited by 130
Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter
Shivakumar, C. V., Brown, D. R., Deb, S., & Deb, S. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6785 · Cited by 120
Sirt1 increases skeletal muscle precursor cell proliferation
Rathbone, C. R., Booth, F. W., & Lees, S. J. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.08.003 · Cited by 120
Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer
Aaltomaa, S., Lipponen, P., Eskelinen, M., Ala-Opas, M., & Kosma, V. M. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990401)39:1<8::aid-pros2>3.0.co;2-n · Cited by 118
Zuo, Z., Dean, N. M., & Honkanen, R. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12250 · Cited by 133
Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA.
Nakanishi, M., Adami, G. R., Robetorye, R. S., Noda, A., Venable, S. F., Dimitrov, D., Pereira-Smith, O. M., & Smith, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4352 · Cited by 119
p53: A Cell Cycle Regulator Activated by DNA Damage
Selivanova, G., & Wiman, K. G. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60253-5 · Cited by 128
p53 and Cell Cycle Effects After DNA Damage
Senturk, E., & Manfredi, J. J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-236-0_4 · Cited by 146
Sliding clamps: A (tail)ored fit
Hingorani, M., & O’Donnell, M. E. (2000) · Current Biology · doi:10.1016/s0960-9822(99)00252-3 · Cited by 129
Prosperi, E. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_15 · Cited by 128
Rousseau, D. L., Cannella, D., Boulaire, J., FITZGERALD, P. J., Fotedar, A., & Fotedar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202681 · Cited by 133
Adenovirus and cell cycle control
Ben-Israel, H., & Kleinberger, T. (2002) · Frontiers in bioscience · doi:10.2741/ben · Cited by 120
Direct recruitment of N-myc to target gene promoters
Mac, S. M., D'Cunha, C. A., & Farnham, P. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200010)29:2<59::aid-mc2>3.0.co;2-6 · Cited by 64
Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
Guan, K. L., Jenkins, C. W., Li, Y., O'Keefe, C. L., Noh, S., Wu, X., Zariwala, M., Matera, A. G., & Xiong, Y. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.1.57 · Cited by 118
Senescent Phenotype Can Be Reversed by Reduction of Caveolin Status
Cho, K. A., Ryu, S. J., Park, J. S., Jang, I. S., Ahn, J. S., Kim, K. T., & Park, S. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208105200 · Cited by 117
Sepp‐Lorenzino, L., & Rosen, N. X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20243 · Cited by 120
Proteasome inhibition suppresses essential immune functions of human CD4+ T cells
Berges, C., Haberstock, H., Fuchs, D., Miltz, M., Sadeghi, M., Opelz, G., Daniel, V., & Naujokat, C. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02761.x · Cited by 127
Cancer chemoresistance: The relationship between p53 and multidrug transporters
Bush, J. A., & Li, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10226 · Cited by 116
Metadata
- Authors
- Waga, S., Hannon, G. J., Beach, D., & Stillman, B.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1994-06
- Volume
- 369
- Issue
- 6481
- Pages
- 574-578
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003282728
- Cited by
- 1,655
- References
- 31
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 21 · 2023: 22 · 2022: 25 · 2021: 17 · 2020: 25 · 2019: 31 · 2018: 23 · 2017: 25 · 2016: 23 · 2015: 25 · 2014: 27 · 2013: 23 · 2012: 49
- FWCI
- 55.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p21, cyclin-dependent kinases, PCNA, proliferating cell nuclear antigen, DNA replication, DNA polymerase delta, p53, cell cycle regulation, DNA repair, protein-protein interaction, tumor suppression
- MeSH terms
- Cell Division, Cell Line, DNA Polymerase III, DNA-Directed DNA Polymerase, DNA Replication, DNA Topoisomerases, Type I, DNA, Viral, Histidine, Humans, Nuclear Proteins, Recombinant Proteins, Simian virus 40, Cyclins, Proliferating Cell Nuclear Antigen, Protein Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.